Citation only
via OpenAlex
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial
Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Pilar Barrúz, Belén Alejos, Gabriel Saiz-Medrano, Julián Nevado, Artur Martin, Francisco Gayá, Rosa de Miguel Buckley, José Ignacio Bernardino, Rocío Montejano, Beatriz Mena-Garay, Julen Cadiñanos, Éric Florence, Fiona Mulcahy
The Lancet HIV · 2021 · ▲ 107 citations
Abstract
This 2021 study in The Lancet HIV examines changes in epigenetic age acceleration two years after starting antiretroviral therapy in adults with HIV.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/s2352-3018(21)00006-0
- Canonical
- link ↗
- Fetched
- 2026-09-09 MST
Cite this
APA
Esteban-Cantos, A., Rodríguez-Centeno, J., Barrúz, P., Alejos, B., Saiz-Medrano, G., Nevado, J., Martin, A., Gayá, F., Buckley, R.D.M., Bernardino, J.I., Montejano, R., Mena-Garay, B., Cadiñanos, J., Florence, �., Mulcahy, F., Bánhegyi, D., Antinori, A., Pozniak, A., Wallet, C., & Raffi, F. (2021). Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. <em>The Lancet HIV</em>. https://doi.org/10.1016/s2352-3018(21)00006-0
Vancouver
Esteban-Cantos A, Rodríguez-Centeno J, Barrúz P, Alejos B, Saiz-Medrano G, Nevado J, et al. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. The Lancet HIV. 2021. doi:10.1016/s2352-3018(21)00006-0.
BibTeX
@article{andrs2021Epigen,
title = {Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial},
author = {Andrés Esteban-Cantos and Javier Rodríguez-Centeno and Pilar Barrúz and Belén Alejos and Gabriel Saiz-Medrano and Julián Nevado and Artur Martin and Francisco Gayá and Rosa de Miguel Buckley and José Ignacio Bernardino and Rocío Montejano and Beatriz Mena-Garay and Julen Cadiñanos and Éric Florence and Fiona Mulcahy and Dénes Bánhegyi and Andrea Antinori and Anton Pozniak and Cédrick Wallet and François Raffi and Berta Rodés and José Ramón Arribas},
journal = {The Lancet HIV},
year = {2021},
doi = {10.1016/s2352-3018(21)00006-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2026
Open access · OA
Epigenetic age acceleration is associated with brain connectivity changes and the risk of major depression after trauma
CanSino Biologics Inc. 2020
Open access · US-GOV
A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada
University of Valencia 2009
Open access · US-GOV
35 Hz Versus 50 Hz Frequency Stimulation Effects on Motor Recovery in Older Adults After Stroke. A Randomized Clinical Trial
Shanghai Zerun Biotechnology Co.,Ltd 2022
Open access · US-GOV
A Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Immunogenicity and Safety of the Recombinant SARS-CoV-2 Vaccine (CHO Cell) in Healthy Adults Aged 60 Years and Above
MAXVAX Biotechnology Limited Liability Company 2024
Open access · US-GOV
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy, Safety and Immunogenicity of Recombinant Zoster Vaccine (CHO Cell) in Adults Aged 40 Years and Above
Shanghai Zerun Biotechnology Co.,Ltd 2021
Open access · US-GOV